BTN3A1 and cancer: In Oncomine database, the expression of BTN3A1 was upregulated in tumor tissues than in normal tissue controls of patients with cancers of brain, cervical, esophageal, head and neck, kidney, and liver, and was downregulated in tumor samples of patients with cancers of breast, lung, ovarian, and prostate (Fig. 1B).